Ensign Peak Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
266,073
+245,923
| +1,220% | +$2.34M | ﹤0.01% | 828 |
|
|
2025
Q1 | $211K | Sell |
20,150
-295,452
| -94% | -$3.09M | ﹤0.01% | 1669 |
|
|
2024
Q4 | $7.44M | Buy |
315,602
+2,850
| +0.9% | +$67.1K | 0.01% | 546 |
|
|
2024
Q3 | $11.2M | Hold |
312,752
| – | – | 0.02% | 439 |
|
|
2024
Q2 | $11M | Sell |
312,752
-298,541
| -49% | -$10.5M | 0.02% | 420 |
|
|
2024
Q1 | $17.4M | Buy |
611,293
+100,000
| +20% | +$2.84M | 0.03% | 347 |
|
|
2023
Q4 | $6.8M | Hold |
511,293
| – | – | 0.01% | 553 |
|
|
2023
Q3 | $4.58M | Hold |
511,293
| – | – | 0.01% | 595 |
|
|
2023
Q2 | $5.75M | Buy |
511,293
+284,667
| +126% | +$3.2M | 0.01% | 548 |
|
|
2023
Q1 | $2.61M | Buy |
226,626
+186,626
| +467% | +$2.15M | 0.01% | 742 |
|
|
2022
Q4 | $464K | Sell |
40,000
-4,270
| -10% | -$49.5K | ﹤0.01% | 1636 |
|
|
2022
Q3 | $562K | Buy |
44,270
+4,270
| +11% | +$54.2K | ﹤0.01% | 1390 |
|
|
2022
Q2 | $275K | Hold |
40,000
| – | – | ﹤0.01% | 1705 |
|
|
2022
Q1 | $386K | Hold |
40,000
| – | – | ﹤0.01% | 1662 |
|
|
2021
Q4 | $476K | Hold |
40,000
| – | – | ﹤0.01% | 1645 |
|
|
2021
Q3 | $650K | Hold |
40,000
| – | – | ﹤0.01% | 1566 |
|
|
2021
Q2 | $842K | Hold |
40,000
| – | – | ﹤0.01% | 1484 |
|
|
2021
Q1 | $621K | Hold |
40,000
| – | – | ﹤0.01% | 1561 |
|
|
2020
Q4 | $840K | Hold |
40,000
| – | – | ﹤0.01% | 1467 |
|
|
2020
Q3 | $808K | Buy |
+40,000
| New | +$808K | ﹤0.01% | 1401 |
|